| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/12/2009 | CA2395458C Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 05/12/2009 | CA2386817C The use of baclofen in the treatment of alcoholism |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2341891C The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/12/2009 | CA2136492C Pharmaceutical composition containing diclofenac and 2-hydroxypropyl-.beta.-cyclodextrin |
| 05/07/2009 | WO2009059239A2 REDUCING Aβ42 LEVELS AND Aβ AGGREGATION |
| 05/07/2009 | WO2009058552A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 05/07/2009 | WO2009058400A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | WO2009058120A1 Nicotinic acetylcholine receptor modulators |
| 05/07/2009 | WO2009058005A2 Unit dosage for brain health |
| 05/07/2009 | WO2009057994A1 Unit dosage for brain health |
| 05/07/2009 | WO2009057664A1 Antibody and use thereof |
| 05/07/2009 | WO2009056990A2 Paliperidone polymorphs |
| 05/07/2009 | WO2009056885A1 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 05/07/2009 | WO2009056851A1 Compositions for treating parkinson's disease |
| 05/07/2009 | WO2009056849A1 Treatment of spinal cord injury |
| 05/07/2009 | WO2009056833A2 Composition |
| 05/07/2009 | WO2009056811A2 Tetrahydrobenzothiazole derivatives with dopamine receptor activity |
| 05/07/2009 | WO2009056805A1 Medicaments |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056632A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | WO2009056625A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | WO2009056600A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | WO2009056509A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 05/07/2009 | WO2009056490A1 NEW ANTIBODIES SPECIFIC OF THE β-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS |
| 05/07/2009 | WO2009055869A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/07/2009 | WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues |
| 05/07/2009 | WO2009055860A1 Transdermal delivery system |
| 05/07/2009 | WO2009055854A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | WO2009037707A3 N-phenyl anthranilic acid derivatives and uses thereof |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2009033489A3 Selective pacl inhibitors for use in the treatment of migraine and headaches |
| 05/07/2009 | WO2009024287A3 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 05/07/2009 | WO2009021957A3 Tricyclic heterocyclic compounds as gaba a modulators |
| 05/07/2009 | WO2009011412A3 Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain |
| 05/07/2009 | WO2008153792A3 Gamma secretase modulators |
| 05/07/2009 | WO2008152068A3 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 05/07/2009 | WO2008112647A3 Nitroxide radical as a treatment for neurodegeneration |
| 05/07/2009 | WO2008077555A3 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 05/07/2009 | WO2008017491A8 Ligustilide derivatives for the treatment of disorders of the central nervous system |
| 05/07/2009 | WO2007015262A3 A process for the preparation of (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl)]piperidine |
| 05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
| 05/07/2009 | US20090118376 Memantine Protects Inflammation-Related Degeneration of Dopamine Neurons Through Inhibition of Over-Activated Microglia and Release of Neurotrophic Factors from Astroglia |
| 05/07/2009 | US20090118368 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof |
| 05/07/2009 | US20090118365 Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain |
| 05/07/2009 | US20090118364 Novel diterpenes from the fruiting body of antrodia camphorata and pharmaceutical compositions thereof |
| 05/07/2009 | US20090118342 Design and synthesis of biotinylated probes for n-acyl-ethanolamines |
| 05/07/2009 | US20090118333 Amides useful as inhibitors of voltage-gated sodium channels |
| 05/07/2009 | US20090118331 Use of Lobeline Epimers in the Treatment of Central Nervous System Diseases, Pathologies, and Drug Abuse |
| 05/07/2009 | US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use |
| 05/07/2009 | US20090118327 Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them |
| 05/07/2009 | US20090118326 Nicotinic Acetylcholine Receptor Modulators |
| 05/07/2009 | US20090118322 Agent for repairing corneal sensitivity containing amide compound |
| 05/07/2009 | US20090118319 Fused and Spirocycle Compounds and the Use Thereof |
| 05/07/2009 | US20090118309 Selective antagonists of A2A adenosine receptors |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118289 (Biphenyl) Carboxylic Acids and Derivatives Thereof |
| 05/07/2009 | US20090118285 Use of kcnq-openers for treating or reducing the symptoms of schizophrenia |
| 05/07/2009 | US20090118283 Amide Derivatives as Kinase Inhibitors |
| 05/07/2009 | US20090118282 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 05/07/2009 | US20090118280 schizophrenia; 1-[4-(4-morpholinylcarbonyl)phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole; administered alone or with another antipsychotic drug |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118274 Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 05/07/2009 | US20090118270 Phosphodiesterase 4 inhibitors |
| 05/07/2009 | US20090118266 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/07/2009 | US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 05/07/2009 | US20090118258 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 05/07/2009 | US20090118257 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
| 05/07/2009 | US20090118254 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/07/2009 | US20090118248 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| 05/07/2009 | US20090118232 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 05/07/2009 | US20090118224 Agent against psychosocial stresses |
| 05/07/2009 | US20090118200 Proline bis-amide orexin receptor antagonists |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118177 Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117639 Neural Progenitor Cell Populations |
| 05/07/2009 | US20090117565 Compositions and methods for diagnosis and treating mood disorders |
| 05/07/2009 | US20090117194 Eukaryotic microorganisms for producing lipids and antioxidants |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117191 Controlled release tramadol formulations |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117130 Kallikrein-inhibitor therapies |
| 05/07/2009 | US20090117120 Transgenic animal model for alzheimer's disease |
| 05/07/2009 | US20090117078 Crosslinked compounds and methods of making and using thereof |
| 05/07/2009 | US20090117064 Stable vitamin b6 derivative |
| 05/07/2009 | US20090117054 Sublingual spray for the treatment of pain |
| 05/07/2009 | US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | CA2704627A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | CA2704533A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | CA2704529A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | CA2704360A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 05/07/2009 | CA2704357A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 05/07/2009 | CA2704250A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/07/2009 | CA2704246A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | CA2704117A1 Transdermal delivery system |